Literature DB >> 6094557

Metabolism of leukotrienes B4 and C4 in the isolated perfused rat lung.

T W Harper, J Y Westcott, N Voelkel, R C Murphy.   

Abstract

Isolated rat lungs perfused with physiological buffer containing leukotriene C4 were found to rapidly metabolize leukotriene C4 to leukotriene C4 sulfoxide, leukotriene D4, and leukotriene E4. Addition of leukotriene C4 to the recirculating perfusion buffer was observed to cause a persistent increase in the pulmonary arterial pressure. Leukotriene C4 instilled into the airway of the perfused lung was also rapidly metabolized to these same products with retention of the products within the lung. In contrast, leukotriene B4 injected into the perfusion fluid was recovered unchanged in the lung effluent. Leukotriene B4 instilled into the airway of the perfused lung was observed to rapidly traverse the alveolar membranes and was recovered intact in the lung effluent. No evidence for formation of the 20-hydroxy or the 20-carboxy metabolites of leukotriene B4 by the isolated perfused rat lung was observed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094557

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Leukotrienes and ARDS.

Authors:  W Seeger; F Grimminger
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  Omega-oxidized leukotriene B4 detected in the broncho-alveolar lavage fluid of patients with non-cardiogenic pulmonary edema, but not in those with cardiogenic edema.

Authors:  W Seeger; F Grimminger; M Barden; G Becker; J Lohmeyer; D Heinrich; H G Lasch
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

3.  Leukotriene and hydroxyeicosatetraenoic acid generation elicited by low doses of Escherichia coli hemolysin in rabbit lungs.

Authors:  F Grimminger; D Walmrath; R G Birkemeyer; S Bhakdi; W Seeger
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

Review 4.  Cellular and humoral mediators of pulmonary edema.

Authors:  A B Malik; W M Selig; K E Burhop
Journal:  Lung       Date:  1985       Impact factor: 2.584

Review 5.  Metabolism of leukotrienes.

Authors:  S Hammarström; L Orning; K Bernström
Journal:  Mol Cell Biochem       Date:  1985-11       Impact factor: 3.396

6.  Metabolism of platelet-activating factor in isolated perfused rat lung.

Authors:  P E Haroldsen; N F Voelkel; J E Henson; P M Henson; R C Murphy
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

7.  The role of blood vessels in the bioconversion of leukotrienes in the pig.

Authors:  S A Galton; P J Piper
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

8.  Inflammatory lipid mediator generation elicited by viable hemolysin-forming Escherichia coli in lung vasculature.

Authors:  F Grimminger; M Thomas; R Obernitz; D Walmrath; S Bhakdi; W Seeger
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

9.  Cyclooxygenase blockade elevates leukotriene E4 production during acute anaphylaxis in sheep.

Authors:  D R Robinson; M Skoskiewicz; K J Bloch; G Castorena; E Hayes; E Lowenstein; C Melvin; F Michelassi; W M Zapol
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

10.  A new treatment for severe pulmonary arterial hypertension based on an old idea: inhibition of 5-lipoxygenase.

Authors:  Norbert F Voelkel; Marc Peters-Golden
Journal:  Pulm Circ       Date:  2020-03-26       Impact factor: 3.017

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.